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The molecular processes involved in retrovirus assembly and budding formation remain poorly understood. The gag-pro-
pol genes of human lymphotropic T-cell virus type II (HTLV-II) are translated into Gag, Gag-Pro, or Gag-Pro-Pol by frameshift
events. In the present study, we investigated the roles of the gag, pro, and pol regions of HTLV-II in viral particle formation
using recombinant baculoviruses. In this study we could successfully produce mature HTLV-II viral particles containing core
structures using a construct expressing the entire gag-pro-pol region. We also investigated the role of the pol region in
particle formation. Deletion of the pol region affects viral particle assembly or release very little, indicating that the gag-pro
region is sufficient for viral particle formation and maturation. Expression of the Gag proteins alone or Gag proteins with
inactivated viral proteases (Pro) resulted in the formation of viral particles; however, these particles did not contain core
structures. These results suggest the intracellular expression of Gag with Pro of HTLV-II is essential for the production of
mature virus particles, whereas that of Pol is not. © 1999 Academic Pressa
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The human lymphotropic T-cell virus type II (HTLV-II) is
retrovirus that is associated with rare hematological
nd neurological disorders (Hall et al., 1996). Sequence
nalysis of the proviral DNA of both human T-cell lym-
hotropic viruses (HTLV), HTLV-I, and HTLV-II, has dem-
nstrated a unique arrangement of the gag and pol
enes (Mador et al., 1989).
The internal core proteins and the enzymes involved in
NA reverse transcription and integration are encoded
y the gag and pol genes, respectively. HTLV-II also has
he pro gene, which codes for the viral protease (Pro) and
s located between the gag and pol genes (Mador et al.,
989). These proteins are initially translated as Gag,
ag-Pro, and Gag-Pro-Pol polyproteins in a frameshift
ashion and then undergo post-translational processing
y Pro, producing the individual proteins. The internal
ore protein Gag of HTLV-II is initially translated as a
olyprotein precursor (Pr53gag) consisting of 429 amino
cid residues; this is also processed by Pro into three
ature forms: p19 (the membrane-associated matrix pro-
ein, MA), p24 (the capsid protein, CA), and p15 (the
ucleocapsid protein, NC) (Shimotohno et al., 1985).
The production of individual HTLV-I Gag proteins or
recursor proteins has been demonstrated using various
xpression systems. The production of p19, p24, and p15
n Escherichia coli (Itamura et al., 1985; Sekine et al.,
989) and of Pr53gag in Saccharomyces cerevisiae (Hay-
1 To whom reprint requests should be addressed. Fax: 03-5285-1189.
-mail: htakahas@nih.go.jp.371kawa et al., 1992) has been reported. In addition, the
roduction of HTLV-I viral particles has been described
n mammalian cells (Derse et al., 1995; Kimata et al.,
994) but not in the baculovirus system.
Expression of human immunodeficiency virus type 1
HIV-1) Gag-Pol is known to produce mature viral parti-
les containing processed structural proteins (Ross et
l., 1991; Shioda and Shibuta, 1990). In contrast, expres-
ion of the Gag precursor protein alone produced mor-
hologically immature particles devoid of electron-dense
ores (Gheysen et al., 1989). This observation indicates
hat maturation of Gag particle requires the coordinated
xpression of the pol gene (Shioda and Shibuta, 1990).
he Pol protein of HIV-1 is processed into protease (Pro),
everse transcriptase (RT), and integrase (IN). Mutational
nalyses in IN and/or RT result in the premature activa-
ion of the HIV-1 Pro, which in turn leads to a reduction in
article production (Bukovsky and Go¨ttlinger, 1996; Quil-
ent et al., 1996). In contrast to HIV, the contribution of the
ol region in the particle production by HTLV-I and
TLV-II has not yet been investigated. In the present
tudy, we produced mature HTLV-II viral particles and
xamined the involvement of the pol region in particle
ormation using a recombinant baculovirus system.
RESULTS
nalysis of virus particle production using the
omplete gag-pro-pol gene product
In HIV-1, the expression of both Gag and Pol pro-
eins with the use of a recombinant virus results in the
rocessing and production of mature particles with0042-6822/99 $30.00
Copyright © 1999 by Academic Press
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372 TAKAHASHI ET AL.lectron-dense cores similar to wild-type HIV virions
Ross et al., 1991). To further evaluate the production of
ature HTLV-II-like particles in insect cells, we pre-
ared recombinant baculoviruses encoding the Gag-
ro-Pol polyproteins. The expression vector pVLPol,
hich contains the entire gag-pro-pol coding region, is
hown in Fig. 1. To investigate the effects of mutations
n the HTLV-II pol coding region, as described later, we
enerated a series of transfer vectors, including pol
egion deletion mutants (pVLRT and pVLPro), pVLStu,
VLSma, and pVLGag (Fig. 1).
Insect cells were infected with the recombinant bac-
lovirus vAcPol and analyzed by immunoblotting with
abbit anti-serum p24. Protein p24 was detected in both
he infected cells (Fig. 2A, lane 1) and the supernatant
Fig. 2B, lane 1), like HTLV-IIa chronically infected Mo-T
ells (Fig. 2A, lane 2) and its supernatant (Fig. 2B, lane 2).
hese results suggest that mature particles are pro-
uced by vAcPol. A 24-kDa protein was also detected
sing HTLV-II patient serum (Fig. 2C, lanes 3 and 4), as
t was using rabbit anti-serum p24 (Fig. 2C, lane 2). As
eported in other retroviruses, phosphorylation of the p24
n mammalian cells was seen as a doublet of bands. The
4-kDa protein was not detected in uninfected insect
ells (Fig. 2C, lane 1).
ffects of mutation of the HTLV-II pol gene on
roduction of p24 capsid protein
The effects of a frameshift mutation in the pol gene on
article morphology have been described for HIV-1. Par-
icles that possess protease but not reverse transcrip-
ase (RT) or integrase (IN) activity have a typical imma-
ure morphology lacking the electron-dense centers, and
he production of p24 is reduced in immunoblotting (Quil-
FIG. 1. Schematic map of six mutant proviruses. The HTLV-II clon
Shimotohno et al., 1985). For each proviral construct, the boundaries of
ndicated by broken lines. Striped areas indicate overlapping regions b
tretches between retroviral proteases. The transfer vectors were desig
ransfer vectors, the recombinant baculoviruses were prepared and desent et al., 1996; Ross et al., 1991; Shioda and Shibuta,
990). Premature termination codons in the HIV-1 pol
ene, particularly involving the IN-coding region, can
lso cause marked reductions in viral particle yield (Buk-
vsky and Go¨ttlinger, 1996). These data suggest an im-
ortant role of the pol region in viral assembly, budding,
nd maturation.
Regarding HTLV-II, pVLRT and pVLPro mutants, which
ack IN (Balakrishnan et al., 1996) or the whole Pol
rotein, did not seem to affect the yield of p24 protein
CA) (Figs. 3A, lanes 5 and 6, and 3B, lanes 4 and 5) in the
aculovirus system. We had the same results from fur-
her deletion extending into the protease region (pro) of
VLStu (Figs. 3A, lane 4, and 3B, lane 3). However, we
ould not deny that p24 contained nonspecifically and
artially processed proteins by viral protease (Pro). As
xpected, when the one of the protease active sites was
emoved in pVLSma, CA was no longer observed (Figs.
A, lane 3, and 3B, lane 2).
To determine whether expression of HTLV-II Gag
rotein is sufficient for viral particle production, we
roduced the Pr53gag through the use of the recombi-
ant baculovirus encoding Pr53gag, vAcGag. As shown
n Fig. 3A (lane 2), a band at 53 kDa was detected in
he extract of high 5 (H5) cells infected with vAcGag.
his 53-kDa protein comigrated with the Pr53gag pro-
uced in the HTLV-IIa-infected Mo-T cell line (Fig. 3A,
ane 8). We also observed several additional bands of
ower molecular mass. However, no molecular species
omigrating with authentic p19, p24, or p15poly-
eptides (Fig. 3A, lane 2) were detected. SDS–PAGE
nalysis of infected H5 cell medium also showed a
ajor band migrating at 53 kDa in cells infected with
AcGag (Fig. 3B, lane 1). The same results were ob-
d for this study was pBR322, 39 HTLV-IIa (Mo-T)-proviral sequence
letions are presented together with the corresponding restriction sites,
n two coding regions. Filled ovals indicate two conserved amino acid
as pVLPol, pVLRT, pVLPro, pVLStu, pVLSma, and pVLGag. Using these
as vAcPol, vAcRT, vAcPro, vAcStu, vAcSma, and vAcGag, respectively.e use
the de
etwee
nated
ignated
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373ANALYSIS OF HTLV-II-LIKE PARTICLE PRODUCTIONained using the recombinant vAcSma (Figs. 3A, lane
, and 3B, lane 2), probably because the protease
egion is also inactivated in this construct. Although
fficiency of Pr53gag production by vAcGag was not so
uch as that produced by vAcSma, the amount of
r53gag in supernatant was parallel to that in infected
ells. From these results, efficiency of the particle
elease from infected cells may not differ between
AcGag and vAcSma.
In both cell extracts and the culture medium, the
mount of Pr53gag was much smaller than that of p24
Figs. 3A, lanes 4–8, and 3B, lanes 3–7). These results
lso support the view that HTLV-II protease protein (Pro)
s clearly active not only in released particles but also in
nfected cells.
FIG. 2. Immunoblotting of the HTLV-II Gag capsid protein p24 (CA)
n full gag-pro-pol genome expression. Insect cells infected with
AcPol. (A) The HTLV-II-specific proteolysis of Gag precursor pro-
uced p24 in H5 cells infected with recombinant vAcPol baculovirus
lane 1) and in the HTLV-IIa chronically infected cells (Mo-T) (lane 2).
hey were examined with the use of 1:2000 diluted rabbit anti-serum
24. (B) In both culture mediums, the production of capsid protein
24 was examined. (C) Cell extracts of uninfected insect cells (H5)
nd Mo-T were immunoblotted by rabbit anti-serum p24 (lanes 1 and
). Cell extracts of Mo-T were examined by immunoblotting with
TLV-II patient sera Vines (lane 3) and B. Vines (lane 4). Ab indicates
ntibody; Ag, antigen.ecombinant baculoviruses
Viral particle formation by these mutant Gag-Pro-Pol
roteins was confirmed through sucrose density gradi-
nt analysis. Fractions were separated on an SDS–poly-
crylamide gel and immunoblotted using HTLV-II patient
erum. In all cases, antigen peaks of p24 were detected
t a sedimentation density of r 5 1.15 (g/ml) (Figs. 4,
–E). To characterize further the recombinant Pr53gag
ecreted into the culture medium, we performed sucrose
ensity gradient analysis (Figs. 5A and 5B). Pr53gag was
ecovered between the densities of 1.15 and 1.20 g/ml,
uggesting that Pr53gag was secreted as viral particles.
he wide distribution of HTLV-II Gag proteins across the
radient may be explained by the production of variable
mounts of complete and incomplete particles.
roduction of HTLV-II-like particles
We confirmed the production of mature HTLV-II-like
articles on electron microscopy resembling those
resent in the Mo-T cell line (Figs. 6A and 6B). The
ecombinant baculoviruses that contain protease active
ites (vAcPol, vAcRT, vAcPro, and vAcStu) produced ma-
ure virus-like particles (Figs. 7A, vAcPol; 7B, vAcRT; 7C,
AcPro; and 7D, vAcStu). Morphological examination by
lectron microscopy confirmed the production of mature
iral particles.
We examined the morphology of the viral particles
roduced from Pr53gag by electron microscopy. The
pherical particles were ;100 nm in diameter, the same
s particles present in the Mo-T cell line, but they did not
ontain central cores (Fig. 8A; indicated by * or **). Our
esults demonstrate that the uncleaved HTLV-II Gag pro-
ein precursor assembles into virus-like particles without
he expression of any other HTLV-II gene products.
DISCUSSION
In this study, we have shown that a recombinant bac-
lovirus expressing Gag-Pro-Pol polyproteins (vAcPol)
ould produce mature particles. The Gag-Pro-Pol
olyprotein construct (pVLPol) should be capable of pro-
ucing all of the proteins required for particle maturation.
e were able to produce mature particles in insect cells
sing vAcPol, and the expected electron-dense centers
ere observed in these particles. The maturation of the
articles was confirmed by immunoblotting and electron
icroscopy. This suggests that HTLV-II protease (Pro) is
xpressed by the recombinant baculovirus, resulting in
he processing of Pr53gag. In support of this, the recom-
inant virus vAcSma, which expresses Gag and Gag with
deleted Pro (Figs. 3A and 3B, indicated by *), did not
roduce mature particles. This result implies that capsid
roduction is associated with the intracellular expres-
ion of viral protease Pro and may not cellular enzymes.
owever, we cannot completely exclude the influence of
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374 TAKAHASHI ET AL.ellular proteases in particle formation at this time. In
act, we did observe other types of immature viral parti-
les with doughnut shapes without electron-dense cen-
ers (Fig. 8B3) (Bazarbachi et al., 1994). In addition, it is
ossible that these could have resulted from processing
y cellular proteases. Moreover, this might explain the
etection of different proteins with unexpected molecular
izes as seen in Figs. 3A (lanes 2 and 3) and 3B (lanes
and 2). This processing by cellular protease were
emarkable in insect cells because in mammalian cells,
nexpected bands were hardly seen (Figs. 3A, lane 8,
nd 3B, lane 7). It seems that the baculovirus system
ould not accurately reproduce the authentic virus situ-
tion.
We also analyzed the roles of Pol and Pro in the
article maturation process. To examine whether Pol and
ro proteins are required for particle maturation or pro-
uction in HTLV-II, we generated deletion mutants of the
ro and pol regions as described in Fig. 1. In HIV-1, when
he gag-pol ORF is truncated to the pro domain to limit
ol expression, some particles lacking the condensed
ore structures were found (Quillent et al., 1996; Ross et
l., 1991). Reduction of particle maturation is thought to
e affected by both the size and the position of the
eletions in pol (Quillent et al., 1996). Furthermore, a
arked reduction in particle production is also seen
hen premature termination codons are introduced into
he HIV-1 IN-coding region (Bukovsky and Go¨ttlinger,
996). In HTLV-II, our experiments demonstrated that
runcation of the pol region in HTLV-II did not affect
article maturation and production as clearly as shown
n HIV-1 (Quillent et al., 1996; Ross et al., 1991; Shioda
FIG. 3. H5 insect cells were infected with the recombinant baculoviru
hich the supernatant fractions (B) were pelleted by ultracentrifugat
embrane was incubated with diluted HTLV-II patient serum (Vines).
ppeared as the HTLV-II Pr53gag polyprotein precursor. The 24-kDa pro
ere also detected in the infected H5 cell supernatants (lanes 1 and 2
o the extracellular space. P24 was also detected (lanes 3–7).nd Shibuta, 1990). Viral particles with the expected
uoyant density and containing p24 were found to be
roduced by all of the pol mutants. With regard to Pro,
nly when one of the two conserved amino acid
tretches that were part of the proteolytic active site
ere truncated (vAcSma), immature particles were pro-
uced. On the other hand, the recombinant baculovirus
xpressing a deletion in the 39 end of the Pro domain
vAcStu) hardly affected particle maturation and produc-
ion. This is partly because the 39 region of the putative
TLV pro region, extending from the second conserved
mino acid stretch to the carboxyl-terminal residue, is
onger than the analogous region of other retrovirus pro
egions (Nam and Hatanaka, 1986). Despite the high
evel of amino acid homology found in this region among
embers of the HTLV family, the biological function of
his region remains unclear. Thus truncation of HTLV-II
ro or Pol may not affect particle formation as clearly as
IV-1 (Quillent et al., 1996; Ross et al., 1991; Shioda and
hibuta, 1990), and it appears that the system of particle
ormation is different between lentiviruses and oncovi-
uses.
One difference in the particle formation between HIV-1
nd HTLV-II is that the HTLV-II Gag-Pro-Pol precursor
rotein (Pr160gag-pro-pol) is produced in much lesser
uantities compared with HIV-1 (1:100) (Hatanaka, 1991).
he reduced production of Pr160gag-pro-pol may be related
o the fact that the frameshift efficiency in translating
ag-Pro-Pol of HTLV-II is very low (0.05%) (Hatanaka,
991). To produce Pr160gag-pro-pol, two frameshift events
re required. In contrast, HIV-1 requires only a single
rameshift to produce Gag-Pol precursor proteins.
h after infection, cell extracts (A) were prepared in sample buffer, after
al pellets were separated on SDS–polyacrylamide gel. The transfer
53-kDa proteins observed in lanes 2 and 3 produced in insect cells
p24) were detected in lanes 4–8. (B) Major bands migrating to 53 kDa
e results suggest that Pr53gag is assembled in H5 cells and releasedses; 72
ion. Vir
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375ANALYSIS OF HTLV-II-LIKE PARTICLE PRODUCTIONOther differences between HTLV-II and HIV-1 are that
he Gag-Pro polyproteins exist independently of Gag-
ro-Pol polyproteins. Hence, mutation of the pol region,
hich affects RT and IN, does not influence protease
ctivity. The Gag-Pro polyproteins should be sufficient to
orm morphologically mature viral particles (Fig. 6C).
FIG. 4. Characterization of particles produced by Mo-T cell (A) line a
ach fraction is indicated on the left. Immunoblot of sucrose density gr
he culture medium, pelleted material from clarified culture medium wa
pm. Fractions were collected and separated on SDS–polyacrylamide g
B. Vines). Antigen (p24) peaks were detected (A–E), sedimenting at ;
articles from recombinant baculoviruses vAcPol (B), vAcRT (C), vAcPrecond, HTLV-II Pro appeared to be very active in in-
ected cells before or during the budding process, sug-
esting that HTLV-II Gag-Pro proteins are autoprocessed
o form mature particles by themselves. Therefore, HTLV
ro is thought to be markedly active, and the precursor
roteins are rapidly cleaved in infected cells. This would
ct cells infected with recombinant baculoviruses (B–E). The density of
fractions are given below. To further characterize the viral antigens in
onated on a linear 20–60% sucrose density gradient for 16 h at 35,000
transfer membrane was incubated with diluted HTLV-II patient serum
l in HTLV-II particles from Mo-T cells (A) and all kinds of HTLV-II-like
nd vAcStu (E). We described the number at the peak of each band.nd inse
adient
s fracti
el. The
1.15 g/m
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376 TAKAHASHI ET AL.xplain the observation that the precursor protein
r53gag, which is indispensable for budding, was barely
etected in the infected cells by immunoblotting (Fig. 3A,
anes 4–8). In contrast, HIV-1 Pro is usually active after
udding, and HIV-1 Pr55gag is readily detectable in in-
ected cells (Bukovsky and Go¨ttlinger, 1996). The differ-
nce in activities between HTLV-II Pro and HIV-1 Pro may
epend on different homologies and cleavage sites of
hese proteases. Thus active HTLV-II Pro in infected cells
ould also explain why little or no Pr160gag-pro-pol or
runcated Pr160gag-pro-pol products were detected.
Although some reports suggest that HIV-1 virion as-
embly could be affected by mutation in the pol region
Engelman et al., 1997; Shin et al., 1994), others do not
lways show a requirement for complete pol region.
oint mutations in IN affect assembly, but deletion of the
T and IN barely affected the particle production (Buk-
vsky and Go¨ttlinger, 1996). We speculate that these
iscrepancies probably are attributed to the effect of the
FIG. 5. Antigen peak of Pr53gag was also detected at ;1.15 g/ml in
AcSma (A) and vAcGag (B). Antigen peaks across the gradient were
bserved.utations on the dimer formation induced by the IN, and
he length of the pol region was not always proportioned
o the suppression of assembly.
Last, we have shown that HTLV-II Pr53gag is produced
n insect cells (H5 cells) using a recombinant baculovirus
AcGag. In the insect system, HTLV-II Pr53gag assembles
t the cell plasma membrane for budding and is released
nto the culture medium as particles of ;100 nm in
iameter (Fig. 8A, indicated by **). Electron microscopy
f thin sections of infected cells showed copious bud-
ing structures of the particles (Fig. 8B, indicated by *),
hich displayed a translucent center and a thick, periph-
ral electron-dense ring surrounded by an outer lipid
ilayer membrane of host-cellular origin that was ac-
FIG. 6. Electron microscopy of Mo-T cells (A and B). Morphologically,
e confirmed mature (A) and immature (B) HTLV-II particles produced
y Mo-T cell line. Magnification bar 5 0.5 mm.
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377ANALYSIS OF HTLV-II-LIKE PARTICLE PRODUCTIONuired during the budding process. In summary, the
rocess of precursor Gag particle formation in these H5
ells closely resembles the budding of immature HIV-1
etrovirions (Carriere et al., 1995, Gelderblom et al., 1987;
heysen et al., 1989; Katsumoto et al., 1987) with respect
o size, physical shape, and typical ring structure. These
mmature retrovirions are also produced by Gag of HIV-2
Luo et al., 1994) and bovine immunodeficiency-like virus
Rasmussen et al., 1990). Studies with moloney murine
eukemia virus, which is also a type C virus, have indi-
ated that core structures are first formed by the asso-
iation of uncleaved Gag precursor monomers (Lu et al.,
979), and proteolytic processing occurs only during or
fter budding (Crawford and Goff, 1985). The HTLV-II-like
articles produced by the recombinant baculovirus vAc-
FIG. 7. Electron microscopy of H5 cells infected with recombinant b
ulture dishes and were fixed. H5 cells were infected with recom
orphologically, we confirmed mature HTLV-II-like particles produced b
ar 5 0.5 mm.ag showed exclusively immature particles without elec-
ron-dense cores composed of capsid proteins.
MATERIALS AND METHODS
eneral DNA methods
Restriction endonucleases and DNA-modifying en-
ymes were used as specified by the manufacturers. The
nzymes used were BamHI, EcoRI, EcoRV, SmaI, StuI,
baI, alkaline phosphatase, and T4 DNA ligase and were
btained from Boehringer Mannheim (Indianapolis, IN).
ll molecular biological manipulations were carried out
y standard methods (Nam et al., 1993). All DNA trans-
ormations were performed with competent E. coli DH 5a
ells (Toyobo).
ruses. Twenty-four hours after infection, H5 cells were removed from
baculoviruses vAcPol (A), vAcRT (B), vAcPro (C), and vAcStu (D).
us recombinant baculovirus-infected insect cells (A–D). Magnificationaculovi
binant
y vario
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378 TAKAHASHI ET AL.onstruction of recombinant baculoviruses
xpressing mutant forms of the gag, pro, and pol
ene regions
Sequence information used for cloning is based on
hat reported by Shimotohno et al. (1985) and involved
he use of the 3.7-kb EcoRV–EcoRI fragment of clone
BR322, which contains the 59 half of the HTLV-IIa pro-
irus. The relative map positions of all of the constructs
re shown in Fig. 1. The purified DNA fragment was
igated with EcoRV--EcoRI-digested pVLPro, pVLRT9. The
equence of the gag-pro gene was generated by PCR
sing 59-CTCCATTCTGGATCCATGGGACAAATC-39 for
he forward primer and 59-TGGAGACCAGAATTCTAAAG-
FIG. 8. Electron microscopy of H5 cells infected with recombinant
aculoviruses vAcSma (A and B). Electron micrograph of insect cells
nfected with the vAcSma recombinant baculovirus, electron-dense
reas protrude from the plasma membrane of vAcSma-infected H5
ells, consistent with early budding (*) and late budding (**). Doughnut-
haped particles are also seen (B3). Magnification bar 5 0.5 mm.CCTGGA-39 for the reverse primer. The underlined se-
uences are the BamHI and EcoRI sites, respectively.
he 1.6-kb gag-pro fragment generated by PCR was
nserted into the BamHI and EcoRI sites of the pVL1392
PharMingen, San Diego, CA) and named pVLPro. The 39
ortion of the pol and the 59 portion of the env gene at
ositions 5089–5960 in clone pBR322 were introduced
nto the EcoRI–BamHI sites of the pBluescript IIKS(1)
Stratagene) by using PCR. Reverse and forward oligo-
ucleotide primers were 59-CCCCCGCCCGGATCCCGT-
GCGATT CCTGA-39 and 59-GGTTGGGATGAAT-
CGCGGGCAGGGCA-39, respectively. The plasmid con-
tructed was named pBS-II39. The underlined sequences
re the BamHI and EcoRI sites. The XbaI–BamHI frag-
ent (nucleotides 3685–5089) in the pBR322 was in-
erted into the BamHI–XbaI site of pBS-II39, which was
alled pBS-II39-II59. pBS-II39-II59 was digested with
coRI. The 1.3-kb EcoRI fragment and the 0.3-kb EcoRV
ragment from pVLPro were ligated with dephosphory-
ated EcoRI and the EcoRV site of pVLRT9, respectively.
he constructed plasmid was designated pVLPol. To
onstruct pVLRT, pVLPol was digested with EcoRI. The
VLRT is a deletion mutant of the IN region (Balakrishnan
t al., 1996). To construct pVLStu and pVLSma, pVLPro
as digested with StuI and SmaI, respectively. PVLGag
as generated by PCR using 59-CTCCATTCTGGATCCAT-
GGACAAATC-39 and 59-CGGGATGGGGAATTCTTA-
ATCTCCCC-39, as forward and reverse primers, respec-
ively. The underlined sequences are the BamHI (for-
ard) and EcoRI (reverse) sites. The 1.3-kb fragment
enerated by PCR was inserted into BamHI and EcoRI
ites of pVL1392.
ells and viruses
The H5 insect cells (InVitrogen) originating from the
varian cells of the cabbage looper Trichoplusia ni were
ropagated at 27°C in TC 100 medium containing 10%
BS. Baculovirus Autographa californica nuclear polyhe-
rosis virus (AcNPV) and recombinant baculovirus were
rown in H5 cells. Recombinant baculoviruses were gen-
rated by cotransfecting H5 cells with wild-type baculo-
irus AcNPV (BaculoGold; PharMingen) viral DNA (0.1
g) together with 2 mg of the transfer vector (pVLPol,
VLRT, pVLPro, pVLStu, pVLSma, and pVLGag) as de-
cribed previously (Smith et al., 1985). Culture superna-
ants were harvested 3 days after transfection. H5 cells
ere infected for 1 h with recombinant viruses in culture
upernatants. The infected cells were seeded in 25-cm2
pinner flasks (Nunclon) and incubated at 27°C. The
ecombinant baculoviruses were designed vAcPol,
AcRT, vAcPro, vAcStu, vAcSma, and vAcGag.
DS–PAGE and polyclonal antibody production
SDS–12% PAGE was used to analyze the virus pro-
eins. Polyclonal antibodies to the HTLV-II p24 were gen-
rated by injecting the highly purified protein into rabbits.
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379ANALYSIS OF HTLV-II-LIKE PARTICLE PRODUCTIONncomplete Freund’s and complete Freund’s adjuvants
DIFCO, Detroit, MI) were used as an adjuvant in a 1:1
atio with the antigen (used according to the instructions
f the manufacturer). One milliliter of the purified p24
rotein was combined with 1.0 ml of the complete
reund’s and injected into the footpad. Then 1.5 ml of the
ame p24 was combined with 1.5 ml of incomplete
reund’s and given as 1.5 ml of subcutaneous injections
very 7 days for three times. After 10 days, 20 ml of the
abbit blood was collected and centrifuged, and the sera
ere frozen at 220°C. Reactivity of the antibody was
etermined by Western blot analysis as described pre-
iously (Tanese et al., 1986).
estern blot analysis of viral proteins
Virus lysates were prepared from infected H5 cells.
ell-free supernatants harvested 72 h after infection
ere centrifuged through 20% sucrose cushions in PBS
y ultracentrifugation at 26,000 rpm (SW 41; Beckman) for
h. Viral pellets were resuspended in PBS and proteins
ere subjected to SDS–12% PAGE. After semidry transfer
o nitrocellulose membranes (Immobilon, Millipore), the
roteins were exposed to a mixture of p24 rabbit poly-
lonal antibodies (1:2000 diluted) or serum (1:2000 di-
uted) from individuals infected with HTLV-II. Blots were
eveloped by enhanced chemiluminescence (SuperSig-
al ULTRA; Pierce) after incubation with horseradish
eroxidase-conjugated anti-rabbit (Souther Biotechnol-
gy Associates) or anti-human antibody (Tago).
ucrose density gradient analysis
Pelleted material from clarified culture medium, pre-
ared as described above, was fractionated on a linear
0–60% sucrose density gradient for 16 h at 35,000 rpm
SW55Ti; Beckman). Fractions (425 ml) were collected
nd 10 ml were subjected to immunoblotting as de-
cribed previously. Densitometry was measured using a
efractometer. The relative antigen (Ag: Pr53gag, p24)
oncentrations were determined by Western blot.
lectron microscopy of wild-type and mutant
iral particles
Twenty-four hours after infection, H5 cells were re-
oved from culture dishes by pipetting, pelleted by low-
peed centrifugation, fixed in 2.5% glutaraldeyde/5.4%
ucrose cacodylate, and then postfixed. After ethanol
ehydration and embedding in epoxy resin, thin sections
ere made, which were further stained with uranyl ace-
ate and lead citrate and examined on a JEM 1200 EX II
oel (Tokyo, Japan) electron microscope.
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